Table 1.

Baseline characteristics and treatment outcome of TNBC patients treated with neoadjuvant chemotherapy (N = 61)

Characteristics	N (%)
Age at diagnosis
Mean ± SD	49.8 ± 11.4
Median (min-max)[IQrange]	48.4 (25.6–76.6) [44.3–58.3]
Stage
II	21 (34.4)
III	40 (65.6)
Ki-67
Mean ± SD	58.2 ± 24.7
Median (min-max)[IQrange]	60 (10–90) [40–80]
Grade
1–2	22 (36.1)
3	39 (63.9)
Chemotherapy
Sequential	52 (85.2)
Concomitant	9 (14.8)
Pathological complete response
Yes	18 (29.5)
No	43 (70.5)